Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Rheinisch-Westfälische Technische Hochschule Aachen, Dissertation, 2022

Keyword: Squamous cell carcinoma
Head
Artificial intelligence
Neck
Basel

Event: Veröffentlichung

(where): Aachen

(who): Universitätsbibliothek der RWTH Aachen

(when): 2022

Creator: Puladi, Behrus

Contributor: Knüchel-Clarke, Ruth
Truhn, Daniel

DOI: 10.18154/RWTH-2022-04697

URN: urn:nbn:de:101:1-2022062011320414243683

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Puladi, Behrus
Knüchel-Clarke, Ruth
Truhn, Daniel
Universitätsbibliothek der RWTH Aachen

Time of origin

2022

Other Objects (12)

Optimized PD-L1 scoring of gastric cancer

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Hochschulschrift

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Optimized PD-L1 scoring of gastric cancer

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Hochschulschrift

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Optimized PD-L1 scoring of gastric cancer

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Hochschulschrift

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Optimized PD-L1 scoring of gastric cancer

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Optimized PD-L1 scoring of gastric cancer

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Optimized PD-L1 scoring of gastric cancer

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?

Regulatory mechanisms of PD-1/PD-L1 in cancers

Related objects

Reset password